Paloma Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-352
| Closed | -$223K | – | 140 |
|
2025
Q1 | $223K | Buy |
+352
| New | +$223K | 0.03% | 97 |
|
2024
Q4 | – | Sell |
-625
| Closed | -$657K | – | 718 |
|
2024
Q3 | $657K | Buy |
625
+62
| +11% | +$65.2K | 0.02% | 306 |
|
2024
Q2 | $592K | Sell |
563
-1,683
| -75% | -$1.77M | 0.02% | 339 |
|
2024
Q1 | $2.16M | Buy |
2,246
+1,197
| +114% | +$1.15M | 0.11% | 89 |
|
2023
Q4 | $921K | Buy |
+1,049
| New | +$921K | 0.03% | 106 |
|
2023
Q3 | – | Sell |
-324
| Closed | -$233K | – | 379 |
|
2023
Q2 | $233K | Buy |
324
+175
| +117% | +$126K | 0.01% | 172 |
|
2023
Q1 | $122K | Buy |
+149
| New | +$122K | ﹤0.01% | 169 |
|
2022
Q4 | – | Sell |
-1,365
| Closed | -$940K | – | 478 |
|
2022
Q3 | $940K | Buy |
+1,365
| New | +$940K | 0.04% | 84 |
|
2022
Q2 | – | Sell |
-781
| Closed | -$546K | – | 1165 |
|
2022
Q1 | $546K | Buy |
781
+441
| +130% | +$308K | 0.02% | 467 |
|
2021
Q4 | $215K | Sell |
340
-8,511
| -96% | -$5.38M | ﹤0.01% | 1278 |
|
2021
Q3 | $5.36M | Buy |
8,851
+7,315
| +476% | +$4.43M | 0.13% | 70 |
|
2021
Q2 | $858K | Sell |
1,536
-8,067
| -84% | -$4.51M | 0.02% | 526 |
|
2021
Q1 | $4.54M | Buy |
+9,603
| New | +$4.54M | 0.1% | 111 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 1851 |
|
2020
Q2 | – | Sell |
-491
| Closed | -$240K | – | 1978 |
|
2020
Q1 | $240K | Sell |
491
-1,328
| -73% | -$649K | 0.01% | 729 |
|
2019
Q4 | $683K | Buy |
1,819
+702
| +63% | +$264K | 0.01% | 957 |
|
2019
Q3 | $310K | Buy |
+1,117
| New | +$310K | 0.01% | 1197 |
|
2019
Q2 | – | Sell |
-1,892
| Closed | -$777K | – | 1739 |
|
2019
Q1 | $777K | Buy |
+1,892
| New | +$777K | 0.02% | 600 |
|
2018
Q4 | – | Sell |
-2,965
| Closed | -$1.2M | – | 1322 |
|
2018
Q3 | $1.2M | Buy |
+2,965
| New | +$1.2M | 0.02% | 465 |
|
2018
Q2 | – | Sell |
-7,301
| Closed | -$2.51M | – | 1572 |
|
2018
Q1 | $2.51M | Buy |
7,301
+3,056
| +72% | +$1.05M | 0.04% | 222 |
|
2017
Q4 | $1.6M | Buy |
+4,245
| New | +$1.6M | 0.02% | 348 |
|
2017
Q3 | – | Sell |
-832
| Closed | -$409K | – | 1696 |
|
2017
Q2 | $409K | Buy |
+832
| New | +$409K | ﹤0.01% | 1175 |
|
2017
Q1 | – | Sell |
-30,067
| Closed | -$11M | – | 1648 |
|
2016
Q4 | $11M | Buy |
30,067
+14,385
| +92% | +$5.28M | 0.11% | 38 |
|
2016
Q3 | $6.31M | Buy |
15,682
+9,257
| +144% | +$3.72M | 0.08% | 44 |
|
2016
Q2 | $2.24M | Buy |
6,425
+1,839
| +40% | +$642K | 0.02% | 423 |
|
2016
Q1 | $1.65M | Sell |
4,586
-3,691
| -45% | -$1.33M | 0.03% | 356 |
|
2015
Q4 | $4.49M | Sell |
8,277
-85,285
| -91% | -$46.3M | 0.12% | 91 |
|
2015
Q3 | $43.5M | Buy |
93,562
+90,425
| +2,883% | +$42.1M | 1.01% | 4 |
|
2015
Q2 | $1.6M | Buy |
+3,137
| New | +$1.6M | 0.03% | 390 |
|
2015
Q1 | – | Sell |
-740
| Closed | -$304K | – | 1262 |
|
2014
Q4 | $304K | Sell |
740
-10,078
| -93% | -$4.14M | 0.01% | 757 |
|
2014
Q3 | $3.9M | Buy |
10,818
+5,701
| +111% | +$2.06M | 0.18% | 108 |
|
2014
Q2 | $1.45M | Sell |
5,117
-2,134
| -29% | -$603K | 0.06% | 236 |
|
2014
Q1 | $2.18M | Buy |
+7,251
| New | +$2.18M | 0.14% | 123 |
|
2013
Q4 | – | Sell |
-23,622
| Closed | -$7.39M | – | 1155 |
|
2013
Q3 | $7.39M | Buy |
23,622
+10,220
| +76% | +$3.2M | 0.29% | 53 |
|
2013
Q2 | $3.01M | Buy |
+13,402
| New | +$3.01M | 0.17% | 114 |
|